Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies
Scientists have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results showed that DMAbs were expre..